{
    "root": "c64664c5-0981-4086-a933-c9c46d34167f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Valsartan",
    "value": "20250201",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "VALSARTAN",
            "code": "80M03YXJ7I"
        }
    ],
    "indications": "valsartan tablets angiotensin ii receptor blocker ( arb ) indicated : • hypertension , lower blood pressure adults children 1 year older . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions ( error ! hyperlink reference valid . ) • heart failure ( nyha class ii iv ) , reduce hospitalization heart failure adults ( error ! hyperlink reference valid . ) • post-myocardial infarction , reduction cardiovascular mortality clinically stable patients left ventricular failure left ventricular dysfunction following myocardial infarction adults ( error ! hyperlink reference valid . )",
    "contraindications": "indication starting dose dose range * hypertension adults ( error ! hyperlink reference valid . ) 80 160 mg daily 80 320 mg daily 1 16 years ( error ! hyperlink reference valid . ) 1 mg/kg daily 40 mg daily 1 4 mg/kg daily 160 mg daily heart failure ( error ! hyperlink reference valid . ) 40 mg twice daily 40 160 mg twice daily post-myocardial infarction ( error ! hyperlink reference valid . ) 20 mg twice daily 20 160 mg twice daily * tolerated patient",
    "warningsAndPrecautions": "valsartan available tablets containing valsartan 160 mg. strengths packaged bottles described . valsartan tablets usp , 160 mg yellowish brown colored , oval shaped , biconvex , film coated tablets , debossed ‘ 184 ’ one side ‘ h ’ side . supplied bottle 30 tablets ndc 82804-154-30 bottle 90 tablets ndc 82804-154-90 store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . protect moisture . dispense tight container ( usp ) .",
    "adverseReactions": "patients known hypersensitivity component . coadminister aliskiren valsartan tablets patients diabetes [ ( error ! hyperlink reference valid . ) ] .",
    "indications_original": "Valsartan tablets are an angiotensin II receptor blocker (ARB) indicated for: • Hypertension , to lower blood pressure in adults and children 1 year and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( Error! Hyperlink reference not valid. ) • Heart failure (NYHA class II to IV), to reduce hospitalization for heart failure in adults ( Error! Hyperlink reference not valid. ) • Post-myocardial infarction , for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults ( Error! Hyperlink reference not valid. )",
    "contraindications_original": "Indication Starting Dose Dose Range* Hypertension Adults ( Error! Hyperlink reference not valid. ) 80 to 160 mg once daily 80 to 320 mg once daily 1 to 16 years ( Error! Hyperlink reference not valid. ) 1 mg/kg once daily Up to 40 mg daily 1 to 4 mg/kg once daily Up to 160 mg daily Heart Failure ( Error! Hyperlink reference not valid. ) 40 mg twice daily 40 to 160 mg twice daily Post-Myocardial Infarction ( Error! Hyperlink reference not valid. ) 20 mg twice daily 20 to 160 mg twice daily *As tolerated by patient",
    "warningsAndPrecautions_original": "Valsartan is available as tablets containing valsartan 160 mg. All strengths are packaged in bottles as described below. \n                     Valsartan Tablets USP, 160 mg are yellowish brown colored, oval shaped, biconvex, film coated tablets, debossed with ‘184’ on one side and ‘H’ on the other side. They are supplied as             \n                     Bottle of 30 Tablets                                                                   NDC 82804-154-30\n                  Bottle of 90 Tablets                                                                   NDC 82804-154-90             \n                     \n                     Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].               Protect from moisture.               Dispense in tight container (USP).",
    "adverseReactions_original": "Do not use in patients with known hypersensitivity to any component.              Do not coadminister aliskiren with valsartan tablets in patients with diabetes              [see Drug Interactions (                \n                     Error! Hyperlink reference not valid.\n                     )]."
}